-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
HPV is the most common sexually transmitted infection (STI)
Infect
Recently, researchers from King's College London revealed that by mid-2019, the HPV vaccination program has prevented approximately 450 cases of cervical cancer and 17,200 cases of precancerous lesions
Prevent Lancet Diagnosis
In England, the vaccine program started in 2008 when a bivalent vaccine-Cervarix-was used to protect women from the two most common types of HPV
In the study, the three cohorts of the vaccinated population included women who were vaccinated with Cervarix between the ages of 12-13, 14-16, and 16-18
They found that among women who were vaccinated between the ages of 14-16, the incidence of cervical cancer was reduced by 62%, and among women who were vaccinated between the ages of 16-18, the incidence of cervical cancer was reduced by 34%
Screening for COVID-19
Original source:
Original source:https:// href="https://" target="_blank" rel="noopener">https:// https://